Zai Lab (MEX:ZLAB N) Change In Receivables: MXN456 Mil (TTM As of Mar. 2026)


MEX:ZLAB N Zai Lab Ltd MEX:ZLAB N
64 GF Score
Price MXN810.00
GF Value MXN1,226.15
! 7 Warning Signs
View Full Analysis

What is Zai Lab Change In Receivables?

Zai Lab MEX:ZLAB N 64 Change In Receivables is MXN456 Mil as of Mar. 2026. GuruFocus rates MEX:ZLAB N with a GF Score™ of 64/100 and a GF Value™ of MXN1,226.15. The stock has 7 warning signs investors should review.

Zai Lab's change in receivables for the quarter that ended in Mar. 2026 was MXN1,040 Mil. It means Zai Lab's Accounts Receivable declined by MXN1,040 Mil from Dec. 2025 to Mar. 2026 .

Zai Lab's change in receivables for the fiscal year that ended in Dec. 2025 was MXN-540 Mil. It means Zai Lab's Accounts Receivable increased by MXN540 Mil from Dec. 2024 to Dec. 2025 .

Zai Lab's Accounts Receivable for the quarter that ended in Mar. 2026 was MXN975 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zai Lab's Days Sales Outstanding for the three months ended in Mar. 2026 was 49.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zai Lab's liquidation value for the three months ended in Mar. 2026 was MXN5,610 Mil.

Zai Lab  (MEX:ZLAB N) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zai Lab's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=975.01/1796.255*91
=49.53

2. In Ben Graham's calculation of liquidation value, Zai Lab's accounts receivable are only considered to be worth 75% of book value:

Zai Lab's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11925.313-7821.792+0.75 * 975.01+0.5 * 1550.109
=5,610

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zai Lab Change In Receivables Related Terms

Zai Lab Change In Receivables Historical Data

* Premium members only.

The historical data trend for Zai Lab's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zai Lab Change In Receivables Chart

Zai Lab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,053.83 490.03 -300.24 -525.84 -539.88

Zai Lab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.89 -214.80 -90.64 -278.85 1,040.09
MEX:ZLAB N
64GF Score
Zai Lab Ltd MEX:ZLAB N
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zai Lab Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN456 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of MXN456 Mil mean?
Zai Lab (MEX:ZLAB N) has a Change In Receivables of MXN456 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Zai Lab and its competitors.
Is Zai Lab's Change In Receivables too high?
Zai Lab's current Change In Receivables is MXN456 Mil. Overall, Zai Lab has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Zai Lab's Change In Receivables compare to STOK and ADMA?
Zai Lab's Change In Receivables of MXN456 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Zai Lab and its competitors. Zai Lab's current Change In Receivables is MXN456 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zai Lab stock overvalued right now?
Zai Lab (MEX:ZLAB N) has a current Change In Receivables of MXN456 Mil. The stock's GF Value™ is MXN1,226.15, compared to a current price of MXN810.00 — trading 33.9% below its estimated fair value. The current Change In Receivables is MXN456 Mil. Zai Lab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Zai Lab (MEX:ZLAB N), the current Change In Receivables is MXN456 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zai Lab (MEX:ZLAB N) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of MXN810.00 is trading 33.9% below its estimated GF Value™ of MXN1,226.15.

Key valuation signals for MEX:ZLAB N:

  • Change In Receivables: MXN456 Mil
  • GF Value™: MXN1,226.15 vs. price of MXN810.00 (33.9% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the MEX:ZLAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
64GF Score

Get the complete analysis for MEX:ZLAB N

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN810.00
Price
MXN1,226.15
GF Value